The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions
Abstract
The 78 kDa glucose-regulated stress protein GRP78 is induced by physiological stress conditions such as hypoxia, low pH, and glucose deprivation which often exist in the microenvironments of solid tumors. Activation of this stress pathway occurs in response to several pro-apoptotic stimuli. In vitro studies have demonstrated a correlation between induced expression of GRP78 and resistance to apoptotic death induced by topoisomerase II-directed drugs. We were interested in characterizing this protein in human breast lesions for potential implications in chemotherapeutic intervention. Surgical specimens of human breast lesions and paired normal tissues from the same patients were flash frozen for these studies. Total RNA and/or protein were extracted from these tissues and used in northern and/or western blot analyses, respectively, to quantify the relative expression of GRP78. Northern blot analysis indicated that 0/5 benign breast lesions, 3/5 estrogen receptor positive (ER+) breast tumors, and 6/9 estrogen receptor negative (ER-) breast tumors exhibited overexpression of GRP78 mRNA compared to paired normal tissues, with fold overexpressions ranging from 1.8 to 20. Western blot analyses correlated with these findings since 0/5 benign breast lesions, 4/6 ER+ breast tumors, and 3/3 ER- breast tumors overexpressed GRP78 protein with fold overexpressions ranging from 1.8 to 19. Immunohistochemical analysis of these tissues demonstrated that the expression of GRP78 was heterogeneous among the cells comprising different normal and malignant glands, but confirmed the overexpression of GRP78 in most of the more aggressive ER- tumors. These results suggest that some breast tumors exhibit adverse microenvironment conditions that induce the overexpression of specific stress genes that may play a role in resistance to apoptosis and decreased chemotherapeutic efficacy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many studies have found evidence of sustained and high-level activation of all three branches of the UPR (PERK, ATF6, IRE1α) in different tumors, including glioblastoma, MM, carcinomas of the breasts, stomach, esophagus, and liver [304,406,407,408,409].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [407]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
CHOMZYNSKI, P. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 62,990
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Gething, M.-J. H., & Sambrook, J. (1992) · Nature · doi:10.1038/355033a0 · Cited by 4,161
(1989) · PubMed · Cited by 3,343
Close Contacts with the Endoplasmic Reticulum as Determinants of Mitochondrial Ca 2+ Responses
Rizzuto, R., Pinton, P., Carrington, W., Fay, F. S., Fogarty, K. E., Lifshitz, L. M., Tuft, R. A., & Pozzan, T. (1998) · Science · doi:10.1126/science.280.5370.1763 · Cited by 2,257
Munro, S., & Pelham, H. (1986) · Cell · doi:10.1016/0092-8674(86)90746-4 · Cited by 1,378
Kozutsumi, Y., Segal, M. S., Normington, K., Gething, M.-J. H., & Sambrook, J. (1988) · Nature · doi:10.1038/332462a0 · Cited by 1,322
Kaufmann, S. H. (1989) · PubMed · Cited by 922
Polypeptide chain binding proteins: Catalysts of protein folding and related processes in cells
Rothman, J. E. (1989) · Cell · doi:10.1016/0092-8674(89)90005-6 · Cited by 873
Cited by
The Role of Endoplasmic Reticulum Stress in Human Pathology
Oakes, S. A., & Papa, F. R. (2014) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104649 · Cited by 1,644
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
Ciocca, D. R., & Calderwood, S. K. (2005) · Cell Stress and Chaperones · doi:10.1379/csc-99r.1 · Cited by 1,420
The glucose-regulated proteins: stress induction and clinical applications
Lee, A. S. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01908-9 · Cited by 1,033
The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress
Lee, A. S. (2005) · Methods · doi:10.1016/j.ymeth.2004.10.010 · Cited by 994
ER chaperones in mammalian development and human diseases
Ni, M., & Lee, A. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.045 · Cited by 751
The role of the unfolded protein response in tumour development: friend or foe?
Ma, Y., & Hendershot, L. M. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1505 · Cited by 712
Reddy, R. K., Mao, C., Baumeister, P., Austin, R. C., Kaufman, R. J., & Lee, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212328200 · Cited by 695
Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential
Lee, A. S. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3701 · Cited by 587
Wang, M., Wey, S., Zhang, Y., Ye, R., & Lee, A. S. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2485 · Cited by 643
Shuda, M., Kondoh, N., Imazeki, N., Tanaka, K., Okada, T., Mori, K., Hada, A., Arai, M., Wakatsuki, T., Matsubara, O., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00029-1 · Cited by 520
Role of Endoplasmic Reticulum Stress in Metabolic Disease and Other Disorders
Özcan, L., & Tabas, I. A. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-043010-144749 · Cited by 471
Endoplasmic Reticulum Stress Signaling in Cancer Cells
Oakes, S. A. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.01.010 · Cited by 397
Endoplasmic Reticulum Stress: Its Role in Disease and Novel Prospects for Therapy
Schönthal, A. H. (2012) · Scientifica · doi:10.6064/2012/857516 · Cited by 357
Muralidharan, S., & Mandrekar, P. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313153 · Cited by 344
Role of mitochondria as the gardens of cell death
Kim, R., Emi, M., & Tanabe, K. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0111-7 · Cited by 336
Targeting the endoplasmic reticulum-stress response as an anticancer strategy
Healy, S., Gorman, A. M., Mousavi-Shafaei, P., Gupta, S., & Samali, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.064 · Cited by 305
Fu, Y., Li, J., & Lee, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4594 · Cited by 307
PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
Bobrovnikova-Marjon, E. V., Grigoriadou, C., Pytel, D., Zhang, F., Ye, J., Koumenis, C., Cavener, D. R., & Diehl, J. A. (2010) · Oncogene · doi:10.1038/onc.2010.153 · Cited by 324
Blais, J. D., Addison, C., Edge, R. E., Falls, T. J., Zhao, H., Wary, K. K., Koumenis, C., Harding, H. P., Ron, D., Holčík, M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01145-06 · Cited by 313
GRP78 as a Novel Predictor of Responsiveness to Chemotherapy in Breast Cancer
Lee, E., Nichols, P. W., SPICER, D. V., Groshen, S. G., Yu, M. C., & Lee, A. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1660 · Cited by 286
Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
Avril, T., Vauléon, É., & Chevet, É. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.72 · Cited by 274
Ermakova, S. P., Kang, B. S., Choi, B. Y., Choi, H. S., Schuster, T. F., Ma, W., Bode, A. M., & Dong, Z. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1586 · Cited by 269
Proteomics of human breast ductal carcinoma in situ.
Wulfkuhle, J. D., Sgroi, D. C., Krutzsch, H. C., McLean, K. C., McGarvey, K. M., Knowlton, M., Chen, S., Shu, H., Şahin, A. A., Kurek, R., et al. (2002) · PubMed · Cited by 256
Tsutsumi, S., Gotoh, T., Tomisato, W., Mima, S., Hoshino, T., Hwang, H.-J., Takenaka, H., Tsuchiya, T., Mori, M., & Mizushima, T. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401436 · Cited by 256
Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease
Lindholm, D., Korhonen, L., Eriksson, O., & Kõks, S. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00048 · Cited by 220
Daneshmand, S., Quek, M. L., van Lin, E. J. N. T., Lee, C., Côté, R. J., Hawes, D., Cai, J., Groshen, S. G., Lieskovsky, G., Skinner, D. G., et al. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.03.014 · Cited by 212
Druggable sensors of the unfolded protein response
Maly, D. J., & Papa, F. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1664 · Cited by 207
Endoplasmic reticulum stress associated responses in cancer
Wang, W., Groenendyk, J., & Michalak, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.012 · Cited by 197
Humphrey, J. S., Price, K., Gupta, E., Baxter, A. R. W., Bird, J., Sonnichsen, D. S., & Naglich, J. G. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-325-5_21 · Cited by 195
Sisinni, L., Pietrafesa, M., Lepore, S., Maddalena, F., Condelli, V., Esposito, F., & Landriscina, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040857 · Cited by 188
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
Davodabadi, F., Sajjadi, S. F., Sarhadi, M., Mirghasemi, S., Hazaveh, M. N., Khosravi, S., Andani, M. K., Cordani, M., Basiri, M., & Ghavami, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176013 · Cited by 203
Unfolded protein response in cancer: the Physician's perspective
Li, X., Zhang, K., & Li, Z. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-8 · Cited by 196
Kim, Y. S., Lillo, A. M., Steiniger, S. C. J., Liu, Y., Ballatore, C., Anichini, A., Mortarini, R., Kaufmann, G. F., Zhou, B., Felding‐Habermann, B., et al. (2006) · Biochemistry · doi:10.1021/bi060264j · Cited by 187
Pharmacological targeting of endoplasmic reticulum stress signaling in cancer
Schönthal, A. H. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.012 · Cited by 181
Zhang, J., Jiang, Y., Jia, Z., Li, Q., Gong, W., Wang, L., Wei, D., Yao, J., Fang, S., & Xie, K. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9051-9 · Cited by 180
Davies, M. P. A., Barraclough, D. L., Stewart, C. E., Joyce, K. A., Eccles, R. M., Barraclough, R., Rudland, P. S., & Sibson, D. R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23479 · Cited by 178
Jorgensen, E. D., Stinson, A., Shan, L., Jin, Y., Gietl, D., & Albino, A. P. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-229 · Cited by 173
Cook, K. L., Shajahan‐Haq, A. N., Wärri, A. M., Lu, J., Hilakivi-Clarke, L. A., & Clarke, R. C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0269 · Cited by 164
Activation and clinical significance of the unfolded protein response in breast cancer
Scriven, P., Coulson, S. G., Haines, R., Balasubramanian, S. P., Cross, S. S., & Wyld, L. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605365 · Cited by 163
Uramoto, H., Sugio, K., Oyama, T., Nakata, S., Ono, K., Yoshimastu, T., Morita, M., & Yasumoto, K. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2004.12.011 · Cited by 154
Dong, D., Ko, B., Baumeister, P., Swenson, S., Costa, F. K., Markland, F. S., Stiles, C., Patterson, J. B., Bates, S. E., & Lee, A. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0754 · Cited by 149
Wang, Q., Zhong-zhou, H., Zhang, J., Wang, Y., Wang, T., Tong, S., Wang, L., Wang, S., & Chen, Y. (2005) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2005.09.010 · Cited by 147
Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response
Chan, S., & Egan, P. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-3455fje · Cited by 149
Pootrakul, L., Datar, R. H., Shi, S., Cai, J., Hawes, D., Groshen, S. G., Lee, A. S., & Côté, R. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0133 · Cited by 142
Obacz, J., Avril, T., Reste, P. L., Urra, H., Quillien, V., Hetz, C. A., & Chevet, É. (2017) · Science Signaling · doi:10.1126/scisignal.aal2323 · Cited by 147
Roller, C., & Maddalo, D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00010 · Cited by 134
Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma
Du, X., Hu, H., Lin, D., Xia, S.-H., Shen, X., Zhang, Y., Luo, M., Feng, Y., Cai, Y., Xu, X., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0159-4 · Cited by 133
Lanni, C., Masi, M., Racchi, M., & Govoni, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0760-2 · Cited by 130
A new tumor-specific variant of GRP78 as target for antibody-based therapy
Rauschert, N., Brändlein, S., Holzinger, E., Hensel, F., Müller–Hermelink, H., & Vollmers, H. P. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.2 · Cited by 130
Vollmers, H. P., & Brändlein, S. (2009) · New Biotechnology · doi:10.1016/j.nbt.2009.03.016 · Cited by 127
Overexpression of glucose-regulated protein 78 in colon cancer
Xing, X., Lai, M., Wang, Y.-H., Xu, E., & Huang, Q. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.07.016 · Cited by 125
Mechanistic Studies of a Peptidic GRP78 Ligand for Cancer Cell-Specific Drug Delivery
Liu, Y. M., Steiniger, S. C. J., Kim, Y. S., Kaufmann, G. F., Felding‐Habermann, B., & Janda, K. D. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060122j · Cited by 124
Chen, Y., Feldman, D. E., Deng, C., Brown, J. A. L., Giacomo, A. F. D., Gaw, A. F., Shi, G., Le, Q., Brown, J. M., & Koong, A. C. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0181 · Cited by 128
Endoplasmic reticulum proteostasis: a key checkpoint in cancer
Oakes, S. A. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00266.2016 · Cited by 128
Bobrovnikova-Marjon, E. V., Pytel, D., Riese, M. J., Vaites, L. P., Singh, N., Koretzky, G. A., Witze, E. S., & Diehl, J. A. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00063-12 · Cited by 126
Dauer, P., Sharma, N., Gupta, V. K., Durden, B. C., Hadad, R., Banerjee, S., Dudeja, V., Saluja, A. K., & Banerjee, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1408-5 · Cited by 123
Tsutsumi, S., Namba, T., Tanaka, K.-I., Arai, Y., Ishihara, T., Aburaya, M., Mima, S., Hoshino, T., & Mizushima, T. (2005) · Oncogene · doi:10.1038/sj.onc.1209139 · Cited by 114
Cook, K. L., Soto‐Pantoja, D. R., Clarke, P. A. G., Cruz, M. I., Zwart, A. L., Wärri, A. M., Hilakivi-Clarke, L. A., Roberts, D. D., & Clarke, R. C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2616 · Cited by 115
Review. The endoplasmic reticulum: a target for new anticancer drugs.
Boelens, J., Lust, S., Offner, F. C., Bracke, M., & Vanhoecke, B. W. A. (2007) · PubMed · Cited by 110
Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78
Katanasaka, Y., Ishii, T., Asai, T., Naitou, H., Maeda, N., Koizumi, F., Miyagawa, S., Ohashi, N., & Oku, N. (2010) · International Journal of Cancer · doi:10.1002/ijc.25276 · Cited by 110
The Cell Biology of the Unfolded Protein Response
Diehl, J. A., Fuchs, S. Y., & Koumenis, C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.018 · Cited by 113
The unfolded protein response as a target for cancer therapy
Nagelkerke, A., Bussink, J., Sweep, F. C. G. J., & Span, P. N. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.006 · Cited by 107
Zheng, Y.-Z., Cao, Z.-G., Hu, X., & Shao, Z. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2967-x · Cited by 99
Tang, J., Guo, Y.-S., Zhang, Y., Yu, X., Li, L., Huang, W., Li, Y., Chen, B., Jiang, J.-L., & Chen, Z.-N. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.60 · Cited by 100
Expression of glucose‐regulated stress protein GRP78 is related to progression of melanoma
Zhuang, L. Q., Scolyer, R. A., Lee, C. S., McCarthy, S. W., Cooper, W. A., Zhang, X. D., Thompson, J. F., & Hersey, P. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03242.x · Cited by 97
Langer, R., Feith, M., Siewert, J. R., Wester, H., & Hoefler, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-70 · Cited by 94
Bartkowiak, K., Effenberger, K. E., Harder, S., Andreas, A., Buck, F., Peter‐Katalinić, J., Pantel, K., & Brandt, B. (2010) · Journal of Proteome Research · doi:10.1021/pr100039d · Cited by 94
Marjon, P., Bobrovnikova-Marjon, E. V., & Abcouwer, S. F. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-4 · Cited by 97
Russell, M. R., Graham, C., D’Amato, A., Gentry‐Maharaj, A., Ryan, A., Kalsi, J., Ainley, C., Whetton, A. D., Menon, U., Jacobs, I. J., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.199 · Cited by 94
Grkovic, S., O׳Reilly, V. C., Han, S., Hong, M., Baxter, R. C., & Firth, S. M. (2012) · Oncogene · doi:10.1038/onc.2012.264 · Cited by 90
Large-Scale Proteomics Analysis of Human Ovarian Cancer for Biomarkers
Bengtsson, S., Krogh, M., Szigyarto, C. A., Uhlén, M., Schedvins, K., Silfverswärd, C., Linder, S., Auer, G., Alaiya, A. A., & James, P. (2007) · Journal of Proteome Research · doi:10.1021/pr060593y · Cited by 88
Potential for therapeutic manipulation of the UPR in disease
Park, S. W., & Özcan, U. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0370-z · Cited by 94
The Potential Role of Intrinsic Hypoxia Markers as Prognostic Variables in Cancer
Moon, E. J., Brizel, D. M., Chi, J., & Dewhirst, M. W. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1623 · Cited by 90
Chang, Y.-W., Tseng, C.-F., Wang, M.-Y., Chang, W.-C., Lee, C.-C., Chen, L.-T., Hung, M.-C., & Su, J.-L. (2016) · Oncogene · doi:10.1038/onc.2015.214 · Cited by 82
Mahadevan, N. R., & Zanetti, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101531 · Cited by 86
Miao, Y. R., Eckhardt, B. L., Cao, Y., Pasqualini, R., Argani, P., Arap, W., Ramsay, R. G., & Anderson, R. L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2991 · Cited by 81
Fasano, E., Serini, S., Piccioni, E., Toesca, A., Monego, G., Cittadini, A. R. M., Ranelletti, F. O., & Calviello, G. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.08.003 · Cited by 80
Ke, P., & Chen, S. S.-L. (2012) · Viruses · doi:10.3390/v4102251 · Cited by 82
Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer
Donohoe, F., Wilkinson, M., Baxter, E., & Brennan, D. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041241 · Cited by 84
Bonsignore, G., Martinotti, S., & Ranzato, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021566 · Cited by 87
Kawiak, A., & Kostecka, A. (2022) · Cancers · doi:10.3390/cancers14020279 · Cited by 94
Chiou, J., Tai, C.-J., Huang, M., Wei, P., Wang, Y.-H., An, J., Wu, C., Liu, T., & Chang, Y. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0718-8 · Cited by 78
Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma
Al-Rawashdeh, F., Scriven, P., Cameron, I. C., Vergani, P., & Wyld, L. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283378405 · Cited by 77
The novel role of pyrvinium in cancer therapy
Momtazi‐borojeni, A. A., Abdollahi, E., Ghasemi, F., Caraglia, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26006 · Cited by 75
Targeting the GRP78 Pathway for Cancer Therapy
Lu, G., Luo, H., & Zhu, X. M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00351 · Cited by 74
Ryan, D., Carberry, S., Murphy, Á. C., Lindner, A. U., Fay, J., Hector, S., McCawley, N., Bacon, O., Concannon, C. G., Kay, E. W., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0948-z · Cited by 74
Goebel, G., Berger, R., Strasak, A. M., Egle, D., Müller‐Holzner, E., Schmidt, S. U., Rainer, J., Presul, E., Parson, W., Lang, S., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.510 · Cited by 71
Yu, D.-H., Macdonald, J. E., Liu, G., Lee, A. S., Ly, M., Davis, T. M. E., Ning, K., Zhou, D., Wong‐Staal, F., & Li, Q. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003951 · Cited by 70
Cisplatin-induced senescence in ovarian cancer cells is mediated by GRP78
Li, W., Wang, W., Dong, H., Li, Y., Li, L., Han, L., Han, Z., Wang, S., Ma, D., & Wang, H. (2014) · Oncology Reports · doi:10.3892/or.2014.3147 · Cited by 69
The unfolded protein response and cancer: A brighter future unfolding?
Scriven, P., Brown, N. J., Pockley, A. G., & Wyld, L. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0150-5 · Cited by 67
Comparative Proteome Analysis of Breast Cancer and Adjacent Normal Breast Tissues in Human
Deng, S.-S., Xing, T., Zhou, H.-Y., Xiong, R.-H., Lu, Y., Wen, B., Liu, S.-Q., & Yang, H.-J. (2006) · Genomics Proteomics & Bioinformatics · doi:10.1016/s1672-0229(06)60029-6 · Cited by 64
Wang, J., Hua, H. M., Ran, Y., Zhang, H., Liu, W., Yang, Z., & Jiang, Y. (2008) · Breast Cancer Research · doi:10.1186/bcr1849 · Cited by 64
Tesei, A., Cortesi, M., Zamagni, A., Arienti, C., Pignatta, S., Zanoni, M., Paolillo, M., Curti, D., Rui, M., Rossi, D., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00711 · Cited by 67
Dai, R., Li, J., Liu, Y., Yan, D., Chen, S., Duan, C., Liu, X., He, T., & Li, H. (2010) · Biological Chemistry · doi:10.1515/bc.2010.072 · Cited by 65
A review of fasting effects on the response of cancer to chemotherapy
Sadeghian, M., Rahmani, S., Khalesi, S., & Hejazi, E. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.037 · Cited by 60
Metabolic dependencies and targets in ovarian cancer
Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 66
Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis
Yeung, B. H. Y., Kwan, B. W. Y., He, Q., Lee, A. S., Liu, J., & Wong, A. S. T. (2008) · Oncogene · doi:10.1038/onc.2008.290 · Cited by 58
Langer, R., Ott, K., Specht, K., Becker, K., Lordick, F., Burian, M., Herrmann, K., Schrattenholz, A. S., Cahill, M. A., Schwaiger, M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0679 · Cited by 59
Olivares‐Illana, V., & Fåhræus, R. (2010) · Oncogene · doi:10.1038/onc.2010.266 · Cited by 58
Trierixin, a Novel Inhibitor of ER Stress-induced XBP1 Activation from Streptomyces sp.
Tashiro, E., Hironiwa, N., Kitagawa, M., Futamura, Y., Suzuki, S.-I., NISHIO, M., & Imoto, M. (2007) · The Journal of Antibiotics · doi:10.1038/ja.2007.69 · Cited by 57
Metadata
- Authors
- Fernandez, P. M., Tabbara, S. O., Jacobs, L. K., Manning, F. C. R., Tsangaris, T. N., Schwartz, A. M., Kennedy, K. A., & Patierno, S. R.
- Affiliations
- George Washington University (US)
- George Washington University Hospital (US)
- Venue
- Breast Cancer Research and Treatment
- Published
- 2000-01
- Volume
- 59
- Issue
- 1
- Pages
- 15-26
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W1997500225
- Cited by
- 338
- References
- 65
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 10 · 2020: 20 · 2019: 15 · 2018: 13 · 2017: 14 · 2016: 13 · 2015: 21 · 2014: 26 · 2013: 19 · 2012: 26
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Breast Cancer Research and Treatment (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- GRP78, breast cancer, benign breast disease, estrogen receptor status, tumor microenvironment, apoptosis resistance, chemoresistance, topoisomerase II inhibitors, tumor aggressiveness
- MeSH terms
- Endoplasmic Reticulum Chaperone BiP, Adult, Aged, Breast Diseases, Breast Neoplasms, Carrier Proteins, Female, Heat-Shock Proteins, Humans, Immunohistochemistry, Middle Aged, Neoplasm Proteins, Gene Expression Regulation, Neoplastic, Apoptosis, Molecular Chaperones, HSP70 Heat-Shock Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.